
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
CTO & Co-Founder, IgniteData
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Advances in technology open door for improved EHR to EDC transfer process.